Upexi, Inc. (UPXI) Stock
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Upexi, Inc.
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
Upexi, Inc. is led by CEO Allan J. Marshall, employs 64 people, headquartered in US, publicly traded since 2021.
Upexi, Inc. (UPXI) stock trades at $0.82 with a market capitalization of $59.93M. The stock is valued at a price-to-earnings (P/E) ratio of -0.22, price-to-book of -1.01, price-to-sales of 2.25. Over the past 52 weeks the stock has ranged between $0.54 and $9.12, and currently trades 91.0% below its 52-week high.
On profitability, Upexi, Inc. generates a return on equity (ROE) of -306.96%, return on capital employed of 36.84%, an operating margin of -75.00%, a net profit margin of -874.01%.
Official website: www.upexi.com